High-throughput flow cytometry for drug discovery: principles, applications, and case studies

被引:29
|
作者
Ding, Mei [1 ]
Kaspersson, Karin [1 ]
Murray, David [2 ]
Bardelle, Catherine [2 ]
机构
[1] AstraZeneca, Innovat Med & Early Dev, Discovery Sci, Pepparedsleden 1, SE-43183 Molndal, Sweden
[2] AstraZeneca, Discovery Sci, Mereside, Alderley Pk, Macclesfield SK10 4TG, Cheshire, England
关键词
MULTIPLEX ASSAY; IDENTIFICATION; SCREEN; INHIBITORS; ENTEROPATHY; MOLECULES; TOXICITY; PLATFORM; PROTEIN;
D O I
10.1016/j.drudis.2017.09.005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Flow cytometry is a technology providing multiparametric analysis of single cells or other suspension particles. High-throughput (HT) flow cytometry has become an attractive screening platform for drug discovery. In this review, we highlight the recent HT flow cytometry applications, and then focus on HT flow cytometry deployment at AstraZeneca (AZ). Practical considerations for successful HT flow cytometry assay development and screening are provided based on experience from four project case studies at AZ. We provide an overview of the scientific rationale, explain why HT flow cytometry was chosen and how HT flow cytometry assays deliver new ways to support the drug discovery process.
引用
收藏
页码:1844 / 1850
页数:7
相关论文
共 50 条
  • [1] High-throughput flow cytometry for drug discovery
    Edwards, Bruce S.
    Young, Susan M.
    Saunders, Matthew J.
    Bologa, Cristian
    Oprea, Tudor I.
    Ye, Richard D.
    Prossnitz, Eric R.
    Graves, Steven W.
    Sklar, Larry A.
    EXPERT OPINION ON DRUG DISCOVERY, 2007, 2 (05) : 685 - 696
  • [2] High-Throughput Flow Cytometry in Drug Discovery
    Ding, Mei
    Edwards, Bruce S.
    SLAS DISCOVERY, 2018, 23 (07) : 599 - 602
  • [3] Recent advances in high-throughput flow cytometry for drug discovery
    Ding, Mei
    Baker, David
    EXPERT OPINION ON DRUG DISCOVERY, 2021, 16 (03) : 303 - 317
  • [4] Flow cytometry for drug discovery, receptor pharmacology and high-throughput screening
    Sklar, Larry A.
    Carter, Mark B.
    Edwards, Bruce S.
    CURRENT OPINION IN PHARMACOLOGY, 2007, 7 (05) : 527 - 534
  • [5] Application of High-Throughput Flow Cytometry in Early Drug Discovery: An AstraZeneca Perspective
    Ding, Mei
    Clark, Roger
    Bardelle, Catherine
    Backmark, Anna
    Norris, Tyrrell
    Williams, Wendy
    Wigglesworth, Mark
    Howes, Rob
    SLAS DISCOVERY, 2018, 23 (07) : 719 - 731
  • [6] Discovery of Regulators of Receptor Internalization with High-Throughput Flow Cytometry
    Wu, Yang
    Tapia, Phillip H.
    Fisher, Gregory W.
    Simons, Peter C.
    Strouse, J. Jacob
    Foutz, Terry
    Waggoner, Alan S.
    Jarvik, Jonathan
    Sklar, Larry A.
    MOLECULAR PHARMACOLOGY, 2012, 82 (04) : 645 - 657
  • [7] High-Throughput Flow Cytometry
    Robinson, J. Paul
    Patsekin, Valery
    Rajwa, Bartek
    Davisson, V. Jo
    Li, Nianyu
    Narayanan, Padmakumar
    GENETIC ENGINEERING & BIOTECHNOLOGY NEWS, 2011, 31 (08): : 20 - +
  • [8] High-Throughput Flow Cytometry Drug Combination Discovery with Novel Synergy Analysis Software, SynScreen
    Perez, Dominique R.
    Edwards, Bruce S.
    Sklar, Larry A.
    Chigaev, Alexandre
    SLAS DISCOVERY, 2018, 23 (07) : 751 - 760
  • [9] A Fully Automated High-Throughput Flow Cytometry Screening System Enabling Phenotypic Drug Discovery
    Joslin, John
    Gilligan, James
    Anderson, Paul
    Garcia, Catherine
    Sharif, Orzala
    Hampton, Janice
    Cohen, Steven
    King, Miranda
    Zhou, Bin
    Jiang, Shumei
    Trussell, Christopher
    Dunn, Robert
    Fathman, John W.
    Snead, Jennifer L.
    Boitano, Anthony E.
    Nguyen, Tommy
    Conner, Michael
    Cooke, Mike
    Harris, Jennifer
    Ainscow, Ed
    Zhou, Yingyao
    Shaw, Chris
    Sipes, Dan
    Mainquist, James
    Lesley, Scott
    SLAS DISCOVERY, 2018, 23 (07) : 697 - 707
  • [10] Novel high-throughput screening technologies - Fluorescence, bioluminescence & flow cytometry aid drug discovery
    Schneider, I
    GENETIC ENGINEERING NEWS, 2003, 23 (06): : 10 - +